Teriparatide biosimilar (National Institute of Dental and Craniofacial Research)

特立帕肽生物类似药(National Institute of Dental and Craniofacial Research)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTeriparatide biosimilar (National Institute of Dental and Craniofacial Research)
Drug Alias Name特立帕肽生物仿制药(National Institute of Dental and Craniofacial Research)rhPTH (1-34) (National Institute of Dental and Craniofacial Research)
ClassificationBiologics > Protein drugs > Recombinant polypeptideBiologics > Biosimilar
Mechanisms of ActionParathyroid hormone replacements
TargetsParathyroid hormone receptor
Therapy Area/IndicationsHypothyroidismHypoparathyroidismDiGeorge Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Active IndicationsHypothyroidismDiGeorge Syndrome
Inactive IndicationsHypoparathyroidism

Other Information

ATC CodeH05AA02
Related LinksN/A